These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 27634464)

  • 1. The gut-kidney axis in chronic renal failure: A new potential target for therapy.
    Khoury T; Tzukert K; Abel R; Abu Rmeileh A; Levi R; Ilan Y
    Hemodial Int; 2017 Jul; 21(3):323-334. PubMed ID: 27634464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The gut-kidney-heart axis in chronic kidney disease.
    Sumida K; Kovesdy CP
    Physiol Int; 2019 Sep; 106(3):195-206. PubMed ID: 31560235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbiota and prebiotics modulation of uremic toxin generation.
    Koppe L; Fouque D
    Panminerva Med; 2017 Jun; 59(2):173-187. PubMed ID: 28001024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uremia and chronic kidney disease: the role of the gut microflora and therapies with pro- and prebiotics.
    Vitetta L; Gobe G
    Mol Nutr Food Res; 2013 May; 57(5):824-32. PubMed ID: 23450842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pathomechanism and treatment of gut microbiota dysbiosis in chronic kidney disease and interventional effects of Chinese herbal medicine].
    Han WB; Liu YL; Wan YG; Sun W; Tu Y; Yang JJ; Wu W; He WM; Yao J
    Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(13):2425-2432. PubMed ID: 28840678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysbiosis-Related Advanced Glycation Endproducts and Trimethylamine N-Oxide in Chronic Kidney Disease.
    Taguchi K; Fukami K; Elias BC; Brooks CR
    Toxins (Basel); 2021 May; 13(5):. PubMed ID: 34069405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut Microbiome in Chronic Kidney Disease.
    Armani RG; Ramezani A; Yasir A; Sharama S; Canziani MEF; Raj DS
    Curr Hypertens Rep; 2017 Apr; 19(4):29. PubMed ID: 28343357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of the Gut Microbiome on Chronic Kidney Disease.
    Sampaio-Maia B; Simões-Silva L; Pestana M; Araujo R; Soares-Silva IJ
    Adv Appl Microbiol; 2016; 96():65-94. PubMed ID: 27565581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From the gastrointestinal tract (GIT) to the kidneys: live bacterial cultures (probiotics) mediating reductions of uremic toxin levels via free radical signaling.
    Vitetta L; Linnane AW; Gobe GC
    Toxins (Basel); 2013 Nov; 5(11):2042-57. PubMed ID: 24212182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the gastrointestinal tract and microbiota on uremic toxins and chronic kidney disease development.
    Briskey D; Tucker P; Johnson DW; Coombes JS
    Clin Exp Nephrol; 2017 Feb; 21(1):7-15. PubMed ID: 26965149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target.
    Ramezani A; Massy ZA; Meijers B; Evenepoel P; Vanholder R; Raj DS
    Am J Kidney Dis; 2016 Mar; 67(3):483-98. PubMed ID: 26590448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The gut-kidney axis.
    Evenepoel P; Poesen R; Meijers B
    Pediatr Nephrol; 2017 Nov; 32(11):2005-2014. PubMed ID: 27848096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of the Intestinal Environment by Lubiprostone Is Associated with Amelioration of Adenine-Induced CKD.
    Mishima E; Fukuda S; Shima H; Hirayama A; Akiyama Y; Takeuchi Y; Fukuda NN; Suzuki T; Suzuki C; Yuri A; Kikuchi K; Tomioka Y; Ito S; Soga T; Abe T
    J Am Soc Nephrol; 2015 Aug; 26(8):1787-94. PubMed ID: 25525179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disorder of gut amino acids metabolism during CKD progression is related with gut microbiota dysbiosis and metagenome change.
    Liu Y; Li J; Yu J; Wang Y; Lu J; Shang EX; Zhu Z; Guo J; Duan J
    J Pharm Biomed Anal; 2018 Feb; 149():425-435. PubMed ID: 29169110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota in chronic kidney disease.
    Cigarran Guldris S; González Parra E; Cases Amenós A
    Nefrologia; 2017; 37(1):9-19. PubMed ID: 27553986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered microbiome in chronic kidney disease: systemic effects of gut-derived uremic toxins.
    Lau WL; Savoj J; Nakata MB; Vaziri ND
    Clin Sci (Lond); 2018 Mar; 132(5):509-522. PubMed ID: 29523750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The crosstalk of gut microbiota and chronic kidney disease: role of inflammation, proteinuria, hypertension, and diabetes mellitus.
    Kanbay M; Onal EM; Afsar B; Dagel T; Yerlikaya A; Covic A; Vaziri ND
    Int Urol Nephrol; 2018 Aug; 50(8):1453-1466. PubMed ID: 29728993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Kidney-Gut Axis: Implications for Nutrition Care.
    Rossi M; Johnson DW; Campbell KL
    J Ren Nutr; 2015 Sep; 25(5):399-403. PubMed ID: 25812908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered intestinal microbial flora and impaired epithelial barrier structure and function in CKD: the nature, mechanisms, consequences and potential treatment.
    Vaziri ND; Zhao YY; Pahl MV
    Nephrol Dial Transplant; 2016 May; 31(5):737-46. PubMed ID: 25883197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiome in chronic kidney disease: challenges and opportunities.
    Nallu A; Sharma S; Ramezani A; Muralidharan J; Raj D
    Transl Res; 2017 Jan; 179():24-37. PubMed ID: 27187743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.